Addition Therapeutics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Addition Therapeutics 2024,Website
www.additiontx.comRevenue
$9.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Addition Therapeutics
Addition Therapeutics is a genomic medicine company focused on developing transformative therapies for people with chronic and rare diseases. The companys all-RNA, non-viral, LNP-based PRINT platform enables precise and durable genetic insertions. This approach is designed to overcome the safety and scalability limitations of existing gene therapy modalities.Explore more
Addition Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Addition Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Addition Therapeutics
Product Launch: Get notified when Addition Therapeutics launches new products
Click to see if Addition Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Addition Therapeutics recently announced quarterly report
Check if Addition Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Addition Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Addition Therapeutics is spiking on competitors!
Addition Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Addition Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Addition Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Addition Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Addition Therapeutics.
Addition Therapeutics financials insights
Gather financial insights about Addition Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$100M
Addition Therapeutics Tech Stack
A closer look at the technologies used by Addition Therapeutics
Addition Therapeutics News & Media
Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
Addition Therapeutics announces multiple oral and poster presentations at the upcoming ASGCT Annual Meeting, May 11-15, 2026, in Boston.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Addition Therapeutics
Sign Up For FreeTo access detailed company insights
Addition Therapeutics is a genomic medicine company focused on developing transformative therapies for people with chronic and rare diseases. The companys all-RNA, non-viral, LNP-based PRINT platform enables precise and durable genetic insertions. This approach is designed to overcome the safety and scalability limitations of existing gene therapy... Read More
